Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Apricus Biosciences Inc (NASDAQ:APRI)

0.35
Delayed Data
As of Aug 29
 +0.01 / +2.94%
Today’s Change
0.28
Today|||52-Week Range
1.99
-64.65%
Year-to-Date
No recent news for Apricus Biosciences Inc.

Today’s Trading

Previous close0.34
Today’s open0.35
Day’s range0.34 - 0.35
Volume164,067
Average volume (3 months)548,579
Market cap$23.2M
Dividend yield--
Data as of 08/29/2016

Growth & Valuation

Earnings growth (last year)+30.45%
Earnings growth (this year)+54.39%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.74%
P/E ratioNM
Price/Sales10.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
KTOVKitov Pharmaceutical...-0.01-0.33%
ONTXOnconova Therapeutic...+0.10+2.99%
CBLICleveland Biolabs In...-0.02-1.04%
CYCCCyclacel Pharmaceuti...-0.42-6.34%
Data as of 08/29/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$4.8M
Annual profit (last year)-$19.0M
Net profit margin-393.12%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer, Secretary &
Director
Richard W. Pascoe
Chief Accounting Officer &
Vice President-Finance
Catherine Bovenizer
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs